Track topics on Twitter Track topics that are important to you
The post Are IL-33 inhibitors the future of atopic dermatitis treatment? appeared first on Pharmaceutical Technology.
Original Article: Are IL-33 inhibitors the future of atopic dermatitis treatment?NEXT ARTICLE
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...
Eczema is a common itchy skin disease characterized by reddening and vesicle formation, which may lead to weeping and crusting. It is endogenous, or constitutional. There are five main types; atopic, seborrhoeic, discoid, gravitational or varicose. ...